diabetes complications/albumin

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 29 rezilta yo

Relation Between Plasma Apelin Level and Diabetic Nephropathy in Type 2 Diabetes Patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Introduction Type 2 Diabetes Mellitus is a metabolic syndrome associated with hyperglycemia due to defect in secretion or action of insulin or both. Long term hyperglycemia leads to complications of microvasculature involving the eyes, kidneys and nerves. Diabetic nephropathy (DN) is the commonest

Effectiveness of SCDM in Patients With Type 2 Diabetes

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Diabetes is a complex, chronic illness requiring continuous medical care with multifactorial risk-reduction strategies beyond glycemic control. At present, about 114 million diabetics and 11.6% incidence rate of diabetes in China have produced huge chronic disease management pressure and created

Arterial Composition and Cardiovascular Outcome in DIabeteS

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

PhD project description The arterial wall in patients with diabetes: Do changes in arterial basement membrane proteins predict future arterial disease? Are remodeling processes altered? Applicant: Anne-Sofie Faarvang Thorsen1, MD Main supervisor: Professor Lars Melholt Rasmussen1 Co-supervisors:

Observational Study to Evaluate the Relationship Between Ketonemia and Renal Function in the Diabetic Patient

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

At the beginning and during the course of the study the glycemic and ketone index obtained by the homologous blood glucose monitoring will be evaluated. During the study, prognostic biomarkers (sP2X7R, KIM-1, sTNFR1, 11-dehydro-tromoxane B2 and 6-keto-prostaglandin-F-1a (PGF1α)), which are presumed

Assessment of the Accuracy of Continuous Glucose Sensors in People With Diabetes Undergoing Haemodialysis

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Diabetic nephropathy is the leading cause of end-stage renal failure (ESRF), representing approximately 40% of people requiring long-term renal replacement therapy and maintenance haemodialysis [1]. Mortality and morbidity within this cohort is high, with the predominant cause being cardiovascular

Financial Incentives for Low Socioeconomic Diabetic Patients

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The study will be performed in primary care clinics in a big Health Funds in Jerusalem and the area (Clalit Health Services). Guidance will be given to the professional staff in the clinics and the pharmacists in the pharmacies of the Health Care Fund. Candidates will be identified from lists of

Automated vs Conventional Perioperative Glycemic Control in Diabetic Patients Undergoing Cardiopulmonary Bypass Surgery

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Upon admission of the patients to the hospital, demographic and physiological data will be collected including waist circumference and BMI. A set of baseline laboratory tests will be done for each patient including: glucose level, Hba1c, lipid profile, creatinine level, liver enzymes and micro

Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness Measurements

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

1. Patient recruitment: eligible patients in the department of endocrinology and department of gastroenterology are encouraged to participate in this study. 2. Non-diabetic patients admitted to the department of gastroenterology for other gastroenterological diseases. If available, these patients'

Transformative Research in Diabetic Nephropathy

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Progress in the area of diabetic kidney research leading to new therapeutics development has been very limited. Indeed, no new medicines indicated for the treatment of chronic kidney disease (CKD) have been approved since ARB's have become standard of care nearly 15 years ago. Several factors

HbA1c Variability in Type II Diabetes

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

One of the last unanswered question in relation to the influence of glycemic control on diabetes complications is whether increased month-to-month changes in blood glucose (as measured by variability in glycated hemoglobin (HbA1c)) compounds the complication rate and if this can be altered with

Qatar Universal Diabetes Outcomes (QUDOS) Study

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

QUDOS aims to gain a better understanding of diabetes in primary and secondary care over a period of 24 months. A range of patients with diabetes will be sampled (including those with Type 1 diabetes as this group is under-studied in Qatar). This will be important in designing appropriate

Evolution of Effectiveness of Diabetes Medical Care in Russia

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Rationale for this Study Primary Existing routine health statistics underestimates the rate of morbidity due to diabetes complications. To provide more realistic estimation of morbidity, repeated epidemiological studies are essential in assessment of tendencies in diabetes medical care at the

Telemedicine Strategy With Home Treatment Save Resources

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Chronic illnesses, such as asthma, diabetes, heart failure, and hypertension, represent a significant burden of disease Chronic diseases also impose huge costs on the health care systems responsible for managing them as well as their significance for those affected. Non-pharmacological treatment is

Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Background Information Diabetes mellitus (DM) affects 9% of the European population and the cost of caring for patients with DM accounts for 15% of the European health care budget expenditure. Al-most 90% of patients have type 2 DM, and absolute numbers are expected to rise in parallel to the

Individually Tailored Treatment of Type 2 Diabetes

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The design is a prospective controlled open-label multicenter intervention study. General practitioners in region of southern Denmark are responsible for the treatment, while central visits for additional data sampling are located at Odense University hospital, Holbaek Hospital, Naestved Hospital,

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye